The Prognostic Value of Circumferential Resection Margin Involvement in Patients with Extraperitoneal Rectal Cancer

被引:1
作者
Shin, Dong Woo [1 ]
Shin, Jin Yong [1 ]
Oh, Sung Jin [1 ]
Park, Jong Kwon [1 ]
Yu, Hyeon [1 ]
Ahn, Min Sung [2 ]
Bae, Ki Beom [2 ]
Hong, Kwan Hee [2 ]
Ji, Yong Il [3 ]
机构
[1] Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Surg, Pusan, South Korea
[2] Inje Univ, Pusan Paik Hosp, Coll Med, Dept Surg, Pusan, South Korea
[3] Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Gynecol & Obstet, Pusan, South Korea
关键词
TOTAL MESORECTAL EXCISION; LOCAL RECURRENCE; POSTOPERATIVE CHEMORADIOTHERAPY; PREOPERATIVE RADIOTHERAPY; RANDOMIZED-TRIAL; FOLLOW-UP; SURGERY; OUTCOMES; SURVIVAL; IMPACT;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
The prognostic influence of circumferential resection margin (CRM) status in extraperitoneal rectal cancer probably differs from that of intraperitoneal rectal cancer because of its different anatomical and biological behaviors. However, previous reports have not provided the data focused on extraperitoneal rectal cancer. Therefore, the aim of this study was to examine the prognostic significance of the CRM status in patients with extraperitoneal rectal cancer. From January 2005 to December 2008, 248 patients were treated for extraperitoneal rectal cancer and enrolled in a prospectively collected database. Extraperitoneal rectal cancer was defined based on tumors located below the anterior peritoneal reflection, as determined intraoperatively by a surgeon. Cox model was used for multivariate analysis to examine risk factors of recurrence and mortality in the 248 patients, and multivariate logistic regression analysis was performed to identify predictors of recurrence and mortality in 135 patients with T3 rectal cancer. CRM involvement for extraperitoneal rectal cancer was present in 29 (11.7%) of the 248 patients, and was the identified predictor of local recurrence, overall recurrence, and death by multivariate Cox analysis. In the 135 patients with T3 cancer, CRM involvement was found to be associated with higher probability of local recurrence and mortality. In extraperitoneal rectal cancer, CRM involvement is an independent risk factor of recurrence and survival. Based on the results of the present study, it seems that CRM involvement in extraperitoneal rectal cancer is considered an indicator for (neo)adjuvant therapy rather than conventional TN status.
引用
收藏
页码:348 / 355
页数:8
相关论文
共 35 条
  • [21] What is the role for the circumferential margin in the modern treatment of rectal cancer?
    Nagtegaal, Iris D.
    Quirke, Phil
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) : 303 - 312
  • [22] A Circumferential Resection Margin of 1 mm Is a Negative Prognostic Factor in Rectal Cancer Patients With and Without Neoadjuvant Chemoradiotherapy
    Park, Jong Seob
    Huh, Jung Wook
    Park, Yoon Ah
    Cho, Yong Beom
    Yun, Seong Hyeon
    Kim, Hee Cheol
    Lee, Woo Yong
    Chun, Ho-Kyung
    [J]. DISEASES OF THE COLON & RECTUM, 2014, 57 (08) : 933 - 940
  • [23] THE PREDICTION OF LOCAL RECURRENCE IN RECTAL ADENOCARCINOMA BY HISTOPATHOLOGICAL EXAMINATION
    QUIRKE, P
    DIXON, MF
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1988, 3 (02) : 127 - 131
  • [24] Preoperative versus postoperative chemoradiotherapy for rectal cancer
    Sauer, R
    Becker, H
    Hohenberger, W
    Rodel, C
    Wittekind, C
    Fietkau, R
    Martus, P
    Tschmelitsch, J
    Hager, E
    Hess, CF
    Karstens, JH
    Liersch, T
    Schmidberger, H
    Raab, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (17) : 1731 - 1740
  • [25] Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
    Sauer, Rolf
    Liersch, Torsten
    Merkel, Susanne
    Fietkau, Rainer
    Hohenberger, Werner
    Hess, Clemens
    Becker, Heinz
    Raab, Hans-Rudolf
    Villanueva, Marie-Therese
    Witzigmann, Helmut
    Wittekind, Christian
    Beissbarth, Tim
    Roedel, Claus
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (16) : 1926 - 1933
  • [26] Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
    Sebag-Montefiore, David
    Stephens, Richard J.
    Steele, Robert
    Monson, John
    Grieve, Robert
    Khanna, Subhash
    Quirke, Phil
    Couture, Jean
    de Metz, Catherine
    Myint, Arthur Sun
    Bessell, Eric
    Griffiths, Gareth
    Thompson, Lindsay C.
    Parmar, Mahesh
    [J]. LANCET, 2009, 373 (9666) : 811 - 820
  • [27] Outcomes following a limited approach to radiotherapy in rectal cancer
    Simunovic, M.
    Jacob, S.
    Coates, A. J.
    Vogt, K.
    Moran, B. J.
    Heald, R. J.
    [J]. BRITISH JOURNAL OF SURGERY, 2011, 98 (10) : 1483 - 1488
  • [28] Preoperative Magnetic Resonance Imaging Assessment of Circumferential Resection Margin Predicts Disease-Free Survival and Local Recurrence: 5-Year Follow-Up Results of the MERCURY Study
    Taylor, Fiona G. M.
    Quirke, Philip
    Heald, Richard J.
    Moran, Brendan J.
    Blomqvist, Lennart
    Swift, Ian R.
    Sebag-Montefiore, David
    Tekkis, Paris
    Brown, Gina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (01) : 34 - U114
  • [29] Comparison of circumferential margin involvement between restorative and nonrestorative resections for rectal cancer
    Tekkis, PP
    Heriot, AG
    Smith, J
    Thompson, MR
    Finan, P
    Stamatakis, JD
    [J]. COLORECTAL DISEASE, 2005, 7 (04) : 369 - 374
  • [30] Adjuvant therapy in rectal cancer: Analysis of stage, sex, and local control - Final report of intergroup 0114
    Tepper, JE
    O'Connell, M
    Niedzwiecki, D
    Hollis, DR
    Benson, AB
    Cummings, B
    Gunderson, LL
    Macdonald, JS
    Martenson, JA
    Mayer, RJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) : 1744 - 1750